Allergic rhinitis (AR) is one of the most common diseases affecting adults and children. It can impair quality of life and, through loss of work and school attendance. Various diagnostic tests and treatments are used in managing patients with this disorder, yet there is considerable variation in their use. This clinical practice guideline was undertaken to optimize the care of patients with AR by addressing quality improvement opportunities through an evaluation of the available evidence and an assessment of the harm-benefit balance of various diagnostic and management options.

➡️Purpose

The primary purpose of this guideline is to address quality improvement opportunities for all clinicians, in any setting, who are likely to manage patients with AR, as well as to optimize patient care, promote effective diagnosis and therapy, and reduce harmful or unnecessary variations in care. The guideline is not intended to replace individualized patient care or clinical judgment.

➡️The target audience

The guideline is intended for all clinicians who are likely to diagnose and manage patients with allergic rhinitis, and it applies to any setting in which allergic rhinitis would be identified, monitored, or managed.